南網能源(003035.SZ):初步判斷2023年全年投產分佈式光伏項目裝機容量增速不會低於去年
格隆匯9月15日丨南網能源(003035.SZ)近期在接待機構投資者調研時表示,公司2023年上半年持續發揮分佈式光伏節能賽道優勢,較2022年底新增投產分佈式光伏項目裝機容量約255MW。
根據公司項目進度並結合過往規律初步判斷公司下半年分佈式光伏投產速度會超過上半年。一般來説分佈式光伏項目的建設週期在3-6個月,也有超過6個月的,綜合考慮公司現有在建以及已通過決策尚未開始建設項目的情況,初步判斷2023年全年投產的分佈式光伏項目裝機容量增速不會低於去年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.